NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitorsCarl Maximilian Thielmann, Klaus Griewank, Johanna Matull et al.|European Journal of Cancer|2021Cited by 33